Santen Pharmaceutical Co Ltd
TSE:4536
Santen Pharmaceutical Co Ltd
Cash from Operating Activities
Santen Pharmaceutical Co Ltd
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Santen Pharmaceutical Co Ltd
TSE:4536
|
Cash from Operating Activities
¥68.1B
|
CAGR 3-Years
23%
|
CAGR 5-Years
13%
|
CAGR 10-Years
13%
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Cash from Operating Activities
¥731.4B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
17%
|
CAGR 10-Years
13%
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Cash from Operating Activities
¥595.3B
|
CAGR 3-Years
47%
|
CAGR 5-Years
47%
|
CAGR 10-Years
25%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Cash from Operating Activities
¥283.2B
|
CAGR 3-Years
7%
|
CAGR 5-Years
16%
|
CAGR 10-Years
4%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Cash from Operating Activities
¥409.9B
|
CAGR 3-Years
26%
|
CAGR 5-Years
28%
|
CAGR 10-Years
23%
|
|
Astellas Pharma Inc
TSE:4503
|
Cash from Operating Activities
¥216.1B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-2%
|
See Also
What is Santen Pharmaceutical Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
68.1B
JPY
Based on the financial report for Dec 31, 2023, Santen Pharmaceutical Co Ltd's Cash from Operating Activities amounts to 68.1B JPY.
What is Santen Pharmaceutical Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
13%
Over the last year, the Cash from Operating Activities growth was 57%. The average annual Cash from Operating Activities growth rates for Santen Pharmaceutical Co Ltd have been 23% over the past three years , 13% over the past five years , and 13% over the past ten years .